trending Market Intelligence /marketintelligence/en/news-insights/trending/_z9aim18fvetfjukmxtaha2 content esgSubNav
In This List

Pivot Pharmaceuticals replaces board chairman

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Pivot Pharmaceuticals replaces board chairman

Pivot Pharmaceuticals Inc. said Ahmad Doroudian will step down as executive chairman of the board.

Doroudian was previously CEO and director of the Canadian company and will remain as an adviser and a significant shareholder.

The biopharmaceutical company appointed Joseph Borovsky as its new chairman, who will also continue in his previous role as executive vice president of product development.